USP16's regulation is particularly crucial in autoimmune responses and inflammatory diseases, such as inflammatory bowel disease (IBD) and colon cancer, underscoring the diverse mechanistic roles of DUBs in NF‐κB signaling control. Here, NFKB1 is linked to inflammatory bowel disease.